Home
About
FAQ
History (3)
A new "FIX" for hemophilia B gene therapy.
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program.
Re: Down-regulation of CatSper1 channel in epididymal spermatozoa contributes to the pathogenesis of asthenozoospermia, whereas up-regulation of the Channel by Sheng-Jing-San treatment improves the sperm motility of asthenozoospermia in rats.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A new "FIX" for hemophilia B gene therapy.
Almeida-Porada G. A new "FIX" for hemophilia B gene therapy. Blood. 2021 May 27; 137(21):2860-2861.
View in:
PubMed
subject areas
Factor IX
Hemophilia B
Humans
authors with profiles
M Graca N. Almeida-Porada MD, PhD